BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24787714)

  • 1. Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis.
    Jongen PJ; Wesnes K; van Geel B; Pop P; Sanders E; Schrijver H; Visser LH; Gilhuis HJ; Sinnige LG; Brands AM;
    PLoS One; 2014; 9(5):e96444. PubMed ID: 24787714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?
    Jongen PJ; Wesnes K; van Geel B; Pop P; Schrijver H; Visser LH; Gilhuis HJ; Sinnige LG; Brands AM
    Mult Scler Int; 2015; 2015():960282. PubMed ID: 26064686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
    BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
    Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
    Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational validity of PASAT and the effect of fatigue and mood in patients with relapsing remitting MS: A functional MRI study.
    Iancheva D; Trenova AG; Terziyski K; Kandilarova S; Mantarova S
    J Eval Clin Pract; 2018 Aug; 24(4):832-838. PubMed ID: 29611255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability.
    Šabanagić-Hajrić S; Suljić E; Kučukalić A
    Psychiatr Danub; 2015 Dec; 27(4):406-12. PubMed ID: 26609654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MS@Work study: a 3-year prospective observational study on factors involved with work participation in patients with relapsing-remitting Multiple Sclerosis.
    van der Hiele K; van Gorp DA; Heerings MA; van Lieshout I; Jongen PJ; Reneman MF; van der Klink JJ; Vosman F; Middelkoop HA; Visser LH;
    BMC Neurol; 2015 Aug; 15():134. PubMed ID: 26264389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
    Jongen PJ; Ruimschotel R; Heerings M; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; Wolper H; van Droffelaar M; Lemmens W; Donders R; Visser LH
    Health Qual Life Outcomes; 2014 Mar; 12():40. PubMed ID: 24646061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of motor-motor and motor-cognitive tasks on balance in patients with multiple sclerosis.
    Mercan F; Kara B; Tiftikcioglu BI; Mercan E; Sertpoyraz FM
    Mult Scler Relat Disord; 2016 May; 7():85-91. PubMed ID: 27237766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial.
    Jongen PJ; van Mastrigt GA; Heerings M; Visser LH; Ruimschotel RP; Hussaarts A; Duyverman L; Valkenburg-Vissers J; Cornelissen J; Bos M; van Droffelaar M; Donders R
    PLoS One; 2019; 14(10):e0223482. PubMed ID: 31600271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring productivity loss in early relapsing-remitting multiple sclerosis.
    Sainz de la Maza S; Maurino J; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco MR; García-Soto JD; Campo-Amigo MD; Navarro-Cantó L; Agüera E; Garcés M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; de Alda LR; Gómez-Ballesteros R; Castillo-Triviño T
    Mult Scler Relat Disord; 2022 Feb; 58():103398. PubMed ID: 35216781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and Fatigue in Patients With Multiple Sclerosis Have No Influence on the Parameters of Cognitive Evoked Potentials.
    Lazarevic S; Azanjac Arsic A; Aleksic D; Toncev G; Miletic-Drakulic S
    J Clin Neurophysiol; 2021 Jan; 38(1):36-42. PubMed ID: 31725033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial.
    Wahls T; Scott MO; Alshare Z; Rubenstein L; Darling W; Carr L; Smith K; Chenard CA; LaRocca N; Snetselaar L
    Trials; 2018 Jun; 19(1):309. PubMed ID: 29866196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.
    Calabrese M; Rinaldi F; Grossi P; Mattisi I; Bernardi V; Favaretto A; Perini P; Gallo P
    Mult Scler; 2010 Oct; 16(10):1220-8. PubMed ID: 20670981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory performance in multiple sclerosis patients correlates with central brain atrophy.
    Hildebrandt H; Hahn HK; Kraus JA; Schulte-Herbrüggen A; Schwarze B; Schwendemann G
    Mult Scler; 2006 Aug; 12(4):428-36. PubMed ID: 16900756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.